All rights reserved
Powered By | 
| Session 1: Placenta Accreta Spectrum (PAS) | ||||
| Moderators: Khalid AlWadi , Sara alrubaish , Fırat ORTAÇ | ||||
| Time | Subject | Speaker | ||
| 9:00 | - | 9:15 | Uterine preservation treatment: a practical approach | Mazin Baazeem |
| 9:15 | - | 9:30 | Radical treatment: surgical tips | David Atallah |
| 9:30 | - | 9:45 | Massive Transfusion Protocols | Eshaq Alshaqaq |
| 9:45 | - | 10:10 | MEMAGO experience | Mahmoud Ghaleb Mutlu Meydanli Waleed Al Jassar Nadine El Kassis |
| 10:10 | - | 10:20 | Discussion | |
| 10:20 | - | 10:40 | Satellite | |
| Session 2: Cervical Cancer Prevention and HPV | ||||
| Moderators: Mohannad AlSabban, Tuğba TEKELİOĞLU, Khaled Gaballah | ||||
| Time | Subject | Speaker | ||
| 10:40 | - | 10:55 | Cervical cancer screening: Is cheaper HPV tests the answer? | Nejat Özgül |
| 10:55 | - | 11:10 | Management of HPV-related cervical lesions during pregnancy | Abdulrahim Gari |
| 11:10 | - | 11:25 | HPV vaccine: Global updates | Murat Gultekin |
| 11:25 | - | 11:40 | HPV vaccination in the MEMAGO region | Eman Alshehri |
| 11:40 | - | 11:55 | Medical treatment of HPV infections | Nisreen Anfinan |
| 11:55 | - | 12:05 | Discussion | |
| 12:05 | - | 13:00 | Praying & Lunch Break | |
| Session 3: Multimodal Management of Cervical Cancer | ||||
| Moderators: Sara Nassir, Bassam Basulaiman, Reem Ujaimi, Zainab Altalal, Hüseyin AKILLI | ||||
| Time | Subject | Speaker | ||
| 13:00 | - | 13:15 | Adjuvant treatment for high and intermediate risk early-stage cervical cancer | Nadeem Aburustum |
| 13:15 | - | 13:45 | Interlace vs. Keynote A018 | Mohamed Aseafan vs. Georges Chahine |
| 13:45 | - | 14:00 | Management of locally advanced cervical cancer in the absence of radiotherapy | Greta Dreyer |
| 14:00 | - | 14:15 | Treatment of residual disease post-CCRT + IO? | Hampig Kourie |
| 14:15 | - | 14:30 | Discussion | |
| 14:30 | - | 14:45 | Coffee Break | |
| 14:45 | - | 15:00 | Recurrence post KEYNOTE-A18: can we rechallenge with IO? | Amr Shafik |
| 15:00 | - | 15:20 | Brachytherapy and interstitial radiotherapy updates | Nemat Hegazy |
| 15:20 | - | 15:35 | SHAPE or no SHAPE | Marie Plante |
| 15:35 | - | 15:50 | Sentinel lymph node in cervical cancer | Ines Zemni |
| 15:50 | - | 16:05 | Criteria for adjuvant treatment in cervical cancer | Safia Yahaui |
| 16:05 | - | 16:20 | Discussion | |
| Session 4: Gestational Trophoblastic Diseases | ||||
| Moderators: Khalid Abdelaziz, Zyiad AlYami | ||||
| Time | Subject | Speaker | ||
| 16:20 | - | 16:35 | GTN update in the MEMAGO region | Reda Hemida |
| 16:35 | - | 16:50 | Rescue treatment or Adriamycin bi-weekly?”. It is very useful for low-income countries | Maha Alsindi |
| 16:50 | - | 17:05 | ERAS in Gynecologic oncology patients | Nikolaos Thomakos |
| 17:05 | - | 17:15 | Discussion | |
| Session 5: Endometrial cancer | ||||
| Moderators: Abdullah Almajnoni, Abdulraheem Shanqiti, Loay Kassem, Ahmad Hakami | ||||
| Time | Subject | Speaker | ||
| 8:30 | - | 8:45 | Implication of the molecular staging on the management of endometrial cancer: Comparative review of various staging classification | Alexandros Rodolakis |
| 8:45 | - | 9:05 | RAINBO Trials and the Molecular Revolution: Redefining Adjuvant Therapy in High-Risk Endometrial Cancer | Wafa Alduwaisan |
| 9:05 | - | 9:25 | IO combinations in advanced and recurrent endometrial cancer | Özden Altundağ |
| 9:25 | - | 9:40 | How to sequence therapy after IO combination? | Emad Shash |
| 9:40 | - | 9:55 | PARP-I in advanced endometrial cancer | Esra Küskü |
| 9:55 | - | 10:10 | LVSI in early stage endometrial cancer: therapeutic implications | Olfa Jaidane |
| 10:10 | - | 10:25 | Discussion | |
| Session 6: Innovations in the conservative management of gynecologic cancers | ||||
| Moderators: Aysun Alci, Abdulaziz Alobaid, Jamel Ben Hassouna, Saad Alrashidi | ||||
| Time | Subject | Speaker | ||
| 10:25 | - | 10:40 | ovarian transposition before radiotherapy: Updates | Wala Mehros |
| 10:40 | - | 10:55 | Uterine transposition: Indications and techniques | Basel Refky |
| 10:55 | - | 11:10 | Uterine transplantation: short- and long-term outcomes | Ismail Al Badawi |
| 11:10 | - | 11:40 | Fertility sparing in in gynecologic cancers: Cervical & Endometrial | Dimitrios Haidopoulos Amal Alsomari |
| 11:40 | - | 11:55 | The future of gynecologic oncology: more conservative and targeted | Çağatay Taşkıran |
| 11:55 | - | 12:10 | Discussion | |
| 12:10 | - | 13:00 | Praying & Lunch Break | |
| Session 7: Ovarian Cancer | ||||
| Moderators: Hisham Abotaleb, Hanan Mal, Waleed Selwi, Mohammed Jamjoom, Ahmed Magdy , Ahmed Nazer | ||||
| Time | Subject | Speaker | ||
| 13:00 | - | 13:15 | Management of an adnexal mass: what a general gynecologist should know | Kareemah Salamah |
| 13:15 | - | 13:30 | How to integrate the molecular subtypes in the management of low grade ovarian carcinoma | Ahmed Alneaami |
| 13:30 | - | 13:45 | Role of MIS in the staging of ovarian cancer and oligometastatic recurrence | Ignacio Zapardiel |
| 13:45 | - | 14:00 | The best maintenance treatment for advanced ovarian cancer | Hashem Al Hashem |
| 14:00 | - | 14:15 | HIPEC and ovarian cancer: It is time to close the debate? | Khalid Akkour |
| 14:15 | - | 14:30 | Neoadjuvant chemotherapy and interval debulking surgery vs primary debulking surgery: Is the TRUST study the answer? | Christina Fotopoulou |
| 14:30 | - | 15:00 | Management of recurrent ovarian cancer | Mehmet Kose |
| 15:00 | - | 15:15 | Discussion | |
| Session 8: Vulvar cancer | ||||
| Moderators: Miral Mashhour , Hanan Alkadri, İlkbal TEMEL , Monia Hechiche | ||||
| Time | Subject | Speaker | ||
| 15:15 | - | 15:30 | U VIN VS D VIN | Abdulmohsen Alkushi |
| 15:30 | - | 15:45 | Who should manage vulvar intraepithelial lesions: Gynecologists or Gynecologic Oncologists? | Khalid Sait |
| 15:45 | - | 16:05 | Vulvar reconstruction | Greta Dreyer |
| 16:05 | - | 16:20 | Sexual Life Post-Treatment | Nadine El Kassis |
| 16:20 | - | 16:35 | Discussion | |
| Session 9: Abstract presentation | ||||
| Moderators: Alaa Ismail | ||||
| Time | Subject | Speaker | ||
| 16:35 | - | 16:55 | Role of V-NOTES and Single-Port Surgery in Gynecologic Oncology | V-notes: Dr. Behzat Can ….................. Single Port: Rami Khalifa |
| 16:55 | - | 17:00 | Abstract Presentation | TBA |
All rights reserved
Powered By |